Tisch MSRCNY, and our FDA-approved stem cell treatment study, have been featured in an article in BioSpace.

Drawing from interviews with Dr. Sadiq and Dr. Harris, this piece highlights the great progress that our stem cell treatment research has seen so far, and the tremendous impact we expect the results to have on treating MS and other neurodegenerative diseases in the future.
 
The piece also highlights the center’s extensive history in working toward finding the cause of MS. As Dr. Sadiq told the publication: “Once you know the cause of something, you can figure out how to prevent it. Finding the cause has been the central question."

Read the full article here.